About Mike

Mike’s practice focuses on advising emerging and growth-stage life sciences and deep tech companies, as well as the funds that invest in them, on matters relating to corporate finance, corporate governance, licensing and other intellectual property-based transactions, mergers and acquisitions, and public offerings.

Mike’s representative matters include new deals for:

Publications

  • Co-author, “A Modeling Study of T-Type Ca2+ Channel Gating and Modulation by L-Cysteine in Rat Nociceptors,” Biophysical Journal 98: 197 – 206, 2010
  • Co-author, “Molecular Mechanisms of Subtype-Specific Inhibition of Neuronal T-Type Calcium Channels by Ascorbate,” Journal of Neuroscience 27: 12577 – 1258, 2007
  • Co-author, “Reducing Agents Sensitize C-Type Nociceptors by Relieving High-Affinity Zinc Inhibition of T-Type Calcium Channels,” Journal of Neuroscience 27: 8250 – 8260, 2007
  • Co-author, “Is There a Role for T-Type Calcium Channels in Peripheral and Central Pain Sensitization?” Molecular Neurobiology 34: 243 – 248, 2006
  • Co-author, “The Role of T-Type Calcium Channels in Epilepsy and Pain,” Current Pharmaceutical Design 12: 2189 – 2197, 2006
  • Co-author, “The Endogenous Redox Agent L-Cysteine Induces T-Type Ca2+ Channel-Dependent Sensitization of a Novel Subpopulation of Rat Peripheral Nociceptors,” Journal of Neuroscience 25: 8766 – 8775, 2005

Education

University of Denver Sturm College of Law
JD, with honors, 2010

University of Virginia
PhD, Neuroscience, 2007

Boston University
MS, Physiology, 2002

Willamette University
BS, Exercise Science, with honors, 2000

Memberships and affiliations

American Bar Association (ABA)

Colorado Bar Association

Massachusetts Bar Association

American Association for the Advancement of Science

Society for Neuroscience